<?xml version="1.0" encoding="UTF-8"?>
<ref id="B103-vaccines-07-00203">
 <label>103.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Vazeille</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Gaborit</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Mousson</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Girod</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Failloux</surname>
    <given-names>A.B.</given-names>
   </name>
  </person-group>
  <article-title>Competitive advantage of a dengue 4 virus when co-infecting the mosquito Aedes aegypti with a dengue 1 virus</article-title>
  <source>BMC Infect. Dis. 2016 16:1</source>
  <year>2016</year>
  <volume>16</volume>
  <elocation-id>318</elocation-id>
  <pub-id pub-id-type="doi">10.1186/s12879-016-1666-0</pub-id>
  <?supplied-pmid 27390932?>
  <pub-id pub-id-type="pmid">27390932</pub-id>
 </element-citation>
</ref>
